Suchen
NLS Pharmaceutics AG
NLSPWZur Watchlist hinzufügen
0.018USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM
mehr Informationen über NLS Pharmaceutics AG Unternehmen
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
NLS Pharmaceutics AG Informationen
BörsenkürzelNLSPW
Name des UnternehmensNLS Pharmaceutics AG
IPO-datumJan 29, 2021
CEOMr. Alexander Zwyer
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
AddresseThe Circle 6
StadtZUERICH
BörseNASDAQ Capital Market Consolidated
LandSwitzerland
Postleitzahl8058
Telefon41445122150
Websitehttps://nlspharma.com/
BörsenkürzelNLSPW
IPO-datumJan 29, 2021
CEOMr. Alexander Zwyer
Führungskräfte von NLS Pharmaceutics AG
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
--
--
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von NLS Pharmaceutics AG?
Die fünf größten Anteilseigner von NLS Pharmaceutics AG sind: Ms. Nicole Fernandez-mcgovern